Skip Navigation


Johns Hopkins Venous Thromboembolism Symposium

conference advertisement with Jack Ansell's headshot

The VTE Collaborative, with support from the Armstrong Institute and Department of Medicine, holds a VTE Symposium every March that highlights some of the latest research on venous thromboembolism and features a keynote speaker who is a national authority in this field.

14th Annual Johns Hopkins Medicine VTE Symposium

Friday, March 25, 2022 | 8am – 1:00pm via Zoom

RegisterDownload the agenda | Flyer | #JHMVTE

Various speakers will provide engaging talks with a focus on reviewing current data and guidelines on VTE prevention, treatment, diagnosis, and best practices. This virtual event will also feature a panel of patients sharing their own personal stories about VTE.

Keynote: Jack E. Ansell, MD, MACP

Progress in Direct Oral Anticoagulant Reversal Therapy

Dr. Jack Ansell is former Chair of Medicine, Lenox Hill Hospital and Professor of Medicine at Hofstra-Northwell School of Medicine. He is a clinical investigator with a principal focus on the clinical problems of thrombosis, antithrombotic therapy, and the application of new modes of delivering and monitoring anticoagulants. Prior to his position in New York, Dr. Ansell was a Professor of Medicine and Vice Chairman of the Department of Medicine at Boston University School of Medicine.

Dr. Ansell has helped to identify and provide an understanding of the problems related to the management of warfarin therapy and was one of the first investigators to identify and show that patients can manage their own therapy through home monitoring. He has been a leader in the promotion of high quality anticoagulation management through the development of anticoagulation clinics and was founder and president for over 15 years of the Anticoagulation Forum, which has grown into a 13,000 member organization representing over 2,500 anticoagulation clinics and interfacing with over 1 million patients. He has more recently been involved with clinical trials of the direct oral anticoagulants and in the development of reversal agents for these anticoagulants.

Dr. Ansell has authored over 250 peer reviewed manuscripts and numerous textbook chapters and a number of texts. He was the lead author for over 10 years of the major consensus guidelines for antithrombotic therapy through the American College of Chest Physicians Consensus Conference on Antithrombotic Therapy, and is lead editor of a unique textbook entitled Managing Oral Anticoagulation: Clinical and Operational Guidelines. Dr. Ansell also held a leadership position in the National Blood Clot Alliance, a patient advocacy group, as past Chair of the Medical and Scientific Advisory Board. Dr. Ansell is a Master of the American College of Physicians and a Fellow of the American Heart Association. Dr. Ansell received his medical degree from the University of Virginia School of Medicine and completed his medical residency at Tufts-New England Medical Center in Boston, followed by a fellowship in Hematology at Boston University and the Boston’s Veterans Administration Hospital.

Speaker: Katie Hoff

World Champion, Olympic Medalist, Author, pulmonary embolism survivor, and the first official National Blood Clot Alliance Ambassador


5 hours CME/CEU credits (AMA /ANCC /ACPE /AAPA)
Free to non-credit attendees

Videos from Past VTE Symposia

Selected videos of past symposia are available. You may need to download Microsoft Silverlight to your computer in order to play them. Download Silverlight.

back to top button